Teva Pharmaceutical Industries Ltd (ADR)
General ticker "TEVA" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $21.6B
Teva Pharmaceutical Industries Ltd (ADR) follows the US Stock Market performance with the rate: 48.0%.
Estimated limits based on current volatility of 2.1%: low 22.17$, high 22.96$
Factors to consider:
- Current price 77.1% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [7.52$, 12.86$]
- 2024-12-30 to 2025-12-30 estimated range: [8.50$, 14.09$]
Financial Metrics affecting the TEVA estimates:
- Positive: Non-GAAP EPS, $ of 2.56 > 2.29
- Positive: 1.03 < Operating profit margin, % of 2.72
- Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85
- Negative: negative Net income
- Positive: Industry inventory ratio change (median), % of -2.41 <= -0.39
Short-term TEVA quotes
Long-term TEVA plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $15,976.00MM | $15,032.00MM | $15,895.00MM |
| Operating Expenses | $14,260.00MM | $17,229.00MM | $15,462.00MM |
| Operating Income | $1,716.00MM | $-2,197.00MM | $433.00MM |
| Non-Operating Income | $-1,058.00MM | $-966.00MM | $-1,057.00MM |
| Interest Expense | $1,058.00MM | $966.00MM | $0.00MM |
| R&D Expense | $967.00MM | $838.00MM | $953.00MM |
| Income(Loss) | $658.00MM | $-3,163.00MM | $-624.00MM |
| Taxes | $211.00MM | $-643.00MM | $-7.00MM |
| Other Income(Loss) | $9.00MM | $21.00MM | $2.00MM |
| Profit(Loss) | $456.00MM | $-2,499.00MM | $-615.00MM |
| Stockholders Equity | $10,278.00MM | $7,804.00MM | $7,506.00MM |
| Inventory | $3,818.00MM | $3,833.00MM | $4,021.00MM |
| Assets | $47,666.00MM | $44,011.00MM | $43,479.00MM |
| Operating Cash Flow | $798.00MM | $1,590.00MM | $1,368.00MM |
| Capital expenditure | $562.00MM | $548.00MM | $526.00MM |
| Investing Cash Flow | $1,523.00MM | $656.00MM | $968.00MM |
| Financing Cash Flow | $-2,172.00MM | $-1,487.00MM | $-1,913.00MM |
| Earnings Per Share* | $0.38 | $-2.12 | $-0.50 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.